Embryonal Tumor Clinical Trials

6 recruiting

Embryonal Tumor Trials at a Glance

12 actively recruiting trials for embryonal tumor are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Phase 1 with 7 trials, with the heaviest enrollment activity in Paris, Hackensack, and Birmingham. Lead sponsors running embryonal tumor studies include Bambino Gesù Hospital and Research Institute, Baylor College of Medicine, and Assistance Publique - Hôpitaux de Paris.

Browse embryonal tumor trials by phase

Treatments under study

About Embryonal Tumor Clinical Trials

Looking for clinical trials for Embryonal Tumor? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Embryonal Tumor trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Embryonal Tumor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 1

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

High Grade GliomaDiffuse Intrinsic Pontine GliomaEmbryonal Tumor+1 more
Baylor College of Medicine56 enrolled1 locationNCT04099797
Recruiting
Phase 2

Embryonal Tumor With Multilayered Rosettes

Embryonal Tumor With Multilayered RosettesEmbryonal Tumor With Multilayered Rosettes, Nos
University of California, San Francisco70 enrolled7 locationsNCT06861244
Recruiting
Phase 1Phase 2

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

MeningiomaRecurrent Diffuse Intrinsic Pontine GliomaHigh Grade Glioma+10 more
Nationwide Children's Hospital65 enrolled4 locationsNCT05278208
Recruiting
Phase 1Phase 2

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

OsteosarcomaEwing SarcomaNeuroblastoma+4 more
Milton S. Hershey Medical Center289 enrolled10 locationsNCT06465199
Recruiting
Phase 1

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

PineoblastomaEmbryonal Tumor With Multilayered RosettesEpendymoma+3 more
Children's National Research Institute12 enrolled1 locationNCT06193759
Recruiting
Early Phase 1

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

CNS Embryonal TumorCNS, Medulloblastoma
C17 Council15 enrolled12 locationsNCT06942039
Recruiting
Phase 1

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Pediatric Brain TumorPineoblastomaMedulloblastoma+7 more
Stanford University18 enrolled1 locationNCT07087002
Recruiting

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

Germ Cell TumorGliomaEpendymoma+10 more
European Organisation for Research and Treatment of Cancer - EORTC1,650 enrolled42 locationsNCT05259605
Recruiting
Phase 1

Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients

Malignant GliomaMalignant Brain TumorEmbryonal Tumor
Assistance Publique - Hôpitaux de Paris24 enrolled3 locationsNCT05293197
Recruiting

ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes

Embryonal Tumor With Multilayered Rosettes
Hackensack Meridian Health100 enrolled1 locationNCT04794686
Recruiting

Rare Embryonal Tumors of the Central Nervous System: International Registry

Embryonal Tumor
Immune Oncology Research Institute300 enrolled11 locationsNCT05711992
Recruiting
Phase 1

GD2-CAR T Cells for Pediatric Brain Tumours

Brain Tumor AdultHigh Grade GliomaDiffuse Intrinsic Pontine Glioma+4 more
Bambino Gesù Hospital and Research Institute54 enrolled1 locationNCT05298995